Category Specific RSS

CYC

The blip in Cyclopharm’s plans for FDA approval

There’s been a small bump in the road in Cyclopharm’s (ASX: CYC) plans to secure regulatory approval for Technegas™, their…

4 years ago

Cyclopharm submits FDA application, expects 50% market share within 3 years

Australian medtech company Cyclopharm (ASX: CYC) is set to add the United States to the list of 59 countries which…

6 years ago